Harris David J, Hilliard Paul E, Jewell Elizabeth S, Brummett Chad M
From the Department of Anesthesiology, University of Michigan Health System, Ann Arbor, MI.
Reg Anesth Pain Med. 2015 May-Jun;40(3):232-8. doi: 10.1097/AAP.0000000000000239.
Effective use of postoperative incentive spirometry improves patient outcomes but is limited by pain after thoracic and upper abdominal surgery. Thoracic epidurals are frequently used to provide analgesia and attenuate postoperative pulmonary dysfunction. We hypothesized that, in patients with thoracic epidurals for thoracic and abdominal surgery, high pain scores would be associated with poorer incentive spirometry performance, even when accounting for other variables.
Retrospective study of 468 patients who underwent upper abdominal or thoracic surgery using postoperative thoracic epidural analgesia between June 1, 2009, and August 31, 2013, at a single tertiary academic center. The association between incentive spirometry performance and pain was assessed as the primary outcome. Other independent predictors of incentive spirometry performance were also identified.
Postoperative incentive spirometry performance was found to be inversely proportional to pain score, which correlated significantly stronger with deep breathing pain compared with pain at rest (-0.33 vs -0.14 on postoperative day 1; -0.23 vs -0.12 on postoperative day 2). Pain with deep breathing was independently associated with poorer incentive spirometry performance in the multivariable linear regression model (P < 0.0001), as was increasing age, female sex, thoracic surgery, and higher American Society of Anesthesiologists (ASA) physical status score.
The present study suggests that pain with deep breathing is more indicative of thoracic epidural efficacy than is pain at rest. Furthermore, incentive spirometry performance could be used as another indicator of thoracic epidural efficacy. This may be particularly useful in patients reporting high pain scores postoperatively.
有效使用术后激励肺活量测定法可改善患者预后,但受胸部和上腹部手术后疼痛的限制。胸段硬膜外镇痛常用于提供镇痛并减轻术后肺功能障碍。我们假设,对于接受胸段硬膜外镇痛进行胸腹部手术的患者,即使考虑其他变量,高疼痛评分也与较差的激励肺活量测定法表现相关。
对2009年6月1日至2013年8月31日期间在单一三级学术中心接受上腹部或胸部手术并使用术后胸段硬膜外镇痛的468例患者进行回顾性研究。评估激励肺活量测定法表现与疼痛之间的关联作为主要结局。还确定了激励肺活量测定法表现的其他独立预测因素。
发现术后激励肺活量测定法表现与疼痛评分成反比,与静息痛相比,深呼吸痛与之的相关性明显更强(术后第1天为-0.33对-0.14;术后第2天为-0.23对-0.12)。在多变量线性回归模型中,深呼吸时的疼痛与较差的激励肺活量测定法表现独立相关(P<0.0001),年龄增加、女性、胸部手术以及较高的美国麻醉医师协会(ASA)身体状况评分也是如此。
本研究表明,深呼吸时的疼痛比静息痛更能表明胸段硬膜外镇痛的效果。此外,激励肺活量测定法表现可作为胸段硬膜外镇痛效果的另一个指标。这对于术后报告高疼痛评分的患者可能特别有用。